Divi's Laboratories Limited (BOM:532488)
India · Delayed Price · Currency is INR 8,056.65
+216.15 (2.76%)
At close: Jul 31, 2026
Divi's Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 25,680 | 21,910 | 16,000 | 18,240 | 29,605 |
Depreciation & Amortization | 4,610 | 3,990 | 3,750 | 3,390 | 3,083 |
Other Amortization | 20 | 30 | 30 | 40 | 31.8 |
Loss (Gain) From Sale of Assets | - | 40 | 40 | 10 | 20.5 |
Loss (Gain) From Sale of Investments | -40 | -50 | -50 | -50 | - |
Provision & Write-off of Bad Debts | 10 | -20 | 40 | - | -20.3 |
Other Operating Activities | -3,890 | -3,830 | -1,130 | -1,230 | 102.7 |
Change in Accounts Receivable | -1,410 | -5,820 | -3,610 | 6,500 | -7,416 |
Change in Inventory | -7,180 | -520 | -1,840 | -1,720 | -6,834 |
Change in Accounts Payable | 2,940 | 950 | 620 | -340 | 342.7 |
Change in Other Net Operating Assets | 6,640 | -150 | -1,240 | -250 | 202.9 |
Operating Cash Flow | 27,380 | 16,530 | 12,610 | 24,590 | 19,118 |
Operating Cash Flow Growth | 65.64% | 31.09% | -48.72% | 28.62% | -1.80% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -25,200 | -14,380 | -10,030 | -4,730 | -7,132 |
Sale of Property, Plant & Equipment | 30 | - | - | - | - |
Investment in Securities | 140 | 3,390 | 4,340 | -24,390 | -15,485 |
Other Investing Activities | 2,840 | 2,950 | 3,000 | 2,050 | 668.1 |
Investing Cash Flow | -22,190 | -8,040 | -2,690 | -27,070 | -21,949 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Repaid | - | - | - | - | -3.5 |
Long-Term Debt Repaid | -20 | -10 | -10 | -10 | -7.9 |
Total Debt Repaid | -20 | -10 | -10 | -10 | -11.4 |
Net Debt Issued (Repaid) | -20 | -10 | -10 | -10 | -11.4 |
Common Dividends Paid | -7,970 | -7,960 | -7,960 | -7,960 | -5,309 |
Other Financing Activities | -50 | -20 | -20 | - | -3.6 |
Financing Cash Flow | -8,040 | -7,990 | -7,990 | -7,970 | -5,324 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | -2,850 | 500 | 1,930 | -10,450 | -8,156 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 2,180 | 2,150 | 2,580 | 19,860 | 11,986 |
Free Cash Flow Growth | 1.40% | -16.67% | -87.01% | 65.69% | 15.61% |
Free Cash Flow Margin | 2.06% | 2.30% | 3.29% | 25.57% | 13.38% |
Free Cash Flow Per Share | 8.21 | 8.10 | 9.72 | 74.81 | 45.15 |
Levered Free Cash Flow | -9,281 | 1,650 | -1,035 | 14,724 | 3,984 |
Unlevered Free Cash Flow | -9,138 | 1,663 | -1,016 | 14,724 | 3,986 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 50 | 20 | 20 | - | 7.3 |
Cash Income Tax Paid | 8,620 | 8,240 | 3,760 | 4,730 | 6,410 |
Change in Working Capital | 990 | -5,540 | -6,070 | 4,190 | -13,705 |